Clinical Trial Update: Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva) [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 COPD trial evaluating tiotropium's ability to relieve dyspnea during exercise. The study was completed and sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED